Docebo Inc
TSX:DCBO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
29.37
71.56
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
DCBO
stock under the Base Case scenario is
46.1
CAD.
Compared to the current market price of 29.37 CAD,
Docebo Inc
is
Undervalued by 36%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Docebo Inc.
| US |
|
Ezenia! Inc
OTC:EZEN
|
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
|
| DE |
|
SAP SE
XETRA:SAP
|
|
| US |
|
Salesforce Inc
NYSE:CRM
|
|
| US |
|
Intuit Inc
NASDAQ:INTU
|
|
| US |
|
Applovin Corp
NASDAQ:APP
|
|
| US |
N
|
NCR Corp
LSE:0K45
|
|
| US |
|
Adobe Inc
NASDAQ:ADBE
|
|
| US |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
|
| US |
|
Synopsys Inc
NASDAQ:SNPS
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Docebo Inc
Balance Sheet Decomposition
Docebo Inc
| Current Assets | 137.3m |
| Cash & Short-Term Investments | 66.1m |
| Receivables | 58.5m |
| Other Current Assets | 12.7m |
| Non-Current Assets | 35.9m |
| PP&E | 4.9m |
| Intangibles | 15.7m |
| Other Non-Current Assets | 15.3m |
| Current Liabilities | 121.1m |
| Accounts Payable | 37.4m |
| Other Current Liabilities | 83.7m |
| Non-Current Liabilities | 6.9m |
| Long-Term Debt | 2m |
| Other Non-Current Liabilities | 4.9m |
Free Cash Flow Analysis
Docebo Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Docebo Inc
|
Revenue
|
236.7m
USD
|
|
Cost of Revenue
|
-45.4m
USD
|
|
Gross Profit
|
191.3m
USD
|
|
Operating Expenses
|
-165.3m
USD
|
|
Operating Income
|
26m
USD
|
|
Other Expenses
|
-3.4m
USD
|
|
Net Income
|
22.6m
USD
|
DCBO Profitability Score
Profitability Due Diligence
Docebo Inc's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Docebo Inc's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
DCBO Solvency Score
Solvency Due Diligence
Docebo Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Docebo Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DCBO Price Targets Summary
Docebo Inc
According to Wall Street analysts, the average 1-year price target for
DCBO
is 38.04 CAD
with a low forecast of 31.31 CAD and a high forecast of 48.3 CAD.
Dividends
Current shareholder yield for
DCBO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
DCBO
stock under the Base Case scenario is
46.1
CAD.
Compared to the current market price of 29.37 CAD,
Docebo Inc
is
Undervalued by 36%.